Moneycontrol
HomeNewsBusinessCoronavirus impact: Sterling and Wilson Solar promoters facilitate repayment of Rs 500 cr
Trending Topics

Coronavirus impact: Sterling and Wilson Solar promoters facilitate repayment of Rs 500 cr

Sterling and Wilson Solar on Tuesday said that its promoters have facilitated repayment of Rs 500 crore as per the revised schedule of repayment approved by the board.

March 31, 2020 / 22:07 IST
Story continues below Advertisement

Sterling and Wilson Solar on Tuesday said that its promoters have facilitated repayment of Rs 500 crore as per the revised schedule of repayment approved by the board.

"Sterling and Wilson Solar Ltd (SWSL) has received additional Rs 500 crore against loans outstanding from Sterling and Wilson Private Limited (SWPL) and its subsidiary Sterling and Wilson International FZE (SWFZE), which was facilitated by Shapoorji Pallonji and Company Private Ltd and Khurshed Daruvala (Promoters), as per the revised schedule of repayment approved by the Board of Directors of SWSL and communicated to the stock exchanges earlier," a company statement said.

Story continues below Advertisement

The proceeds have been utilised to reduce our external borrowings by an equivalent amount.

An amount of Rs 1,000 crore had already been repaid from the date of listing till December 31, 2019.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show